The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
3
- 1
Katzman, Alexander
Born in November 1970Individual (1 offspring)Officer
2016-01-15 ~ nowOF - Director → CIF 0Mr Alexander Katzman
Born in November 1970Individual (1 offspring)Person with significant control 2016-04-06 ~ nowPE - Ownership of shares – More than 25% but not more than 50% → CIF 0 - 2
Mevzos, Dimitri
Born in August 1972Individual (3 offsprings)Officer 2015-06-16 ~ nowOF - Director → CIF 0 - 3
Mr Dmitri Dan Spivak
Born in June 1968Individual (1 offspring)Person with significant control 2016-04-06 ~ nowPE - Ownership of shares – More than 25% but not more than 50% → CIF 0
Ceased
4
- 1
Adilova, Dinara
Business Executive born in June 1985IndividualOfficer 2016-01-01 ~ 2020-06-20OF - Director → CIF 0Ms Dinara Adilova
Born in June 1985IndividualPerson with significant control 2016-04-06 ~ 2020-06-20PE - Ownership of shares – More than 25% but not more than 50% → CIF 0 - 2
Curran, Alan
Consultant born in May 1932Individual (6 offsprings)Officer 2014-11-25 ~ 2015-06-16OF - Director → CIF 0 - 3
5th Floor, Morley House, 314-322 Regent Street, London, United KingdomActive Corporate (2 parents, 91 offsprings)Equity (Company account)10,000 GBP2023-12-31Officer2014-11-25 ~ 2017-11-07PE - Secretary → CIF 0 - 4CORPSEC LIMITED2nd Floor, 201, Haverstock Hill, London, EnglandActive Corporate (1 parent, 6 offsprings)Equity (Company account)1 GBP2024-10-31Officer2017-12-18 ~ 2019-09-26PE - Secretary → CIF 0
Company in focus
DASAPHARM LIMITED
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Intangible Assets
60,615 USD2024-12-31
Property, Plant & Equipment
2,032 USD2023-12-31
Fixed Assets
60,615 USD2024-12-31
2,032 USD2023-12-31
Total Inventories
1,488,380 USD2024-12-31
494,230 USD2023-12-31
Debtors
1,148,423 USD2024-12-31
987,739 USD2023-12-31
Cash at bank and in hand
2,079,544 USD2024-12-31
871,546 USD2023-12-31
Current Assets
4,716,347 USD2024-12-31
2,353,515 USD2023-12-31
Net Current Assets/Liabilities
-180,576 USD2024-12-31
-134,172 USD2023-12-31
Total Assets Less Current Liabilities
-119,961 USD2024-12-31
-132,140 USD2023-12-31
Net Assets/Liabilities
-119,961 USD2024-12-31
-132,140 USD2023-12-31
Equity
Called up share capital
134 USD2024-12-31
134 USD2023-12-31
Retained earnings (accumulated losses)
-120,095 USD2024-12-31
-132,274 USD2023-12-31
Equity
-119,961 USD2024-12-31
-132,140 USD2023-12-31
Average Number of Employees
02024-01-01 ~ 2024-12-31
02023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Development expenditure
66,500 USD2024-12-31
Intangible Assets - Gross Cost
66,500 USD2024-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Development expenditure
5,885 USD2024-01-01 ~ 2024-12-31
Intangible Assets - Increase From Amortisation Charge for Year
5,885 USD2024-01-01 ~ 2024-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
5,885 USD2024-12-31
Intangible Assets - Accumulated Amortisation & Impairment
5,885 USD2024-12-31
Intangible Assets
Development expenditure
60,615 USD2024-12-31
Property, Plant & Equipment - Gross Cost
Tools/Equipment for furniture and fittings
18,716 USD2024-12-31
18,716 USD2024-01-01
Property, Plant & Equipment - Gross Cost
18,716 USD2024-12-31
18,716 USD2024-01-01
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Tools/Equipment for furniture and fittings
18,716 USD2024-12-31
16,684 USD2024-01-01
Property, Plant & Equipment - Accumulated Depreciation & Impairment
18,716 USD2024-12-31
16,684 USD2024-01-01
Property, Plant & Equipment - Increase or decrease in depreciation and impairment
Tools/Equipment for furniture and fittings
2,032 USD2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
2,032 USD2024-01-01 ~ 2024-12-31
Finished Goods/Goods for Resale
1,488,380 USD2024-12-31
494,230 USD2023-12-31
Trade Debtors/Trade Receivables
1,112,740 USD2024-12-31
979,770 USD2023-12-31
Other Debtors
3,476 USD2024-12-31
3,476 USD2023-12-31
Prepayments/Accrued Income
26,200 USD2024-12-31
539 USD2023-12-31
Trade Creditors/Trade Payables
Amounts falling due within one year
1,494,781 USD2024-12-31
385,216 USD2023-12-31
Amounts owed to group undertakings and participating interests
Amounts falling due within one year
1,693,838 USD2024-12-31
1,388,126 USD2023-12-31
Accrued Liabilities/Deferred Income
Amounts falling due within one year
1,708,304 USD2024-12-31
714,345 USD2023-12-31
- Registered number 09325869
DASAPHARM LIMITED
Info2nd Floor, 201 Haverstock Hill, London NW3 4QGPRIVATE LIMITED COMPANY incorporated on 2014-11-25 (11 years). The company status is Active.The last date of confirmation statement was made at 2025-03-23CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.